Marcel Zighelboim

Title: Marcel Zighelboim: Innovator in Skin Disorder Treatments

Introduction: Marcel Zighelboim is an accomplished inventor based in Kiriat Motzkin, Israel. He holds a patent that represents a significant advancement in the treatment of various skin and mucosal disorders. His expertise and innovative approach contribute to the ongoing battle against dermatological conditions.

Latest Patents: Marcel Zighelboim's notable patent is focused on the "Treatment of skin disorders with compositions comprising an EGFR inhibitor." This invention involves the use of compositions that include at least one EGFR inhibitor, specifically topical compositions containing erlotinib. The patented formulation is beneficial for treating, preventing, or alleviating various skin and mucosal disorders such as psoriasis, eczema, ichthyosis vulgaris, and non-melanoma skin cancer, among others.

Career Highlights: Zigheboim is currently associated with Sol-Gel Technologies Ltd., where he continues to leverage his expertise in dermatological therapies. His patent enhances the company's portfolio, reflecting his commitment to innovative research and development in medicinal formulations.

Collaborations: Throughout his career, Marcel has collaborated with prominent colleagues like Moshe Arkin and Ori Nov. These partnerships highlight a collective effort to push the boundaries of dermatological science and improve treatment options for patients suffering from skin disorders.

Conclusion: Marcel Zighelboim stands out as a dedicated inventor whose contributions have the potential to make a meaningful impact in dermatology. With his focus on innovative treatments for skin disorders, he exemplifies the spirit of invention and collaboration within the medical research community.